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22q11.2 deletion carriers show specific cognitive
deficits, and 30% of them develop schizophrenia.
One of the disrupted genes is ZDHHC8, which en-
codes for a palmitoyltransferase. We show that
Zdhhc8-deficient mice have reduced palmitoylation
of proteins that regulate axonal growth and branch-
ing. Analysis of axonal projections of pyramidal
neurons from both Zdhhc8-deficient and Df(16)A+/
mice, which model the 22q11.2 deletion, revealed
deficits in axonal growth and terminal arborization,
which can be prevented by reintroduction of active
ZDHHC8 protein. Impaired terminal arborization is
accompanied by a reduction in the strength of syn-
aptic connections and altered functional connectivity
and working memory. The effect of ZDHHC8 is medi-
ated in part via Cdc42-dependent modulation of Akt/
Gsk3b signaling at the tip of the axon and can be
reversed by pharmacologically decreasing Gsk3b
activity during postnatal brain development. Our
findings provide valuable mechanistic insights into
the cognitive and psychiatric symptoms associated
with a schizophrenia-predisposing mutation.
INTRODUCTION
Deletions of the 22q11.2 locus are among the most common
chromosomal abnormalities and occur predominantly de novo
(McDonald-McGinn et al., 2001). Children with the 22q11.2 dele-
tion show a spectrum of cognitive deficits (Woodin et al., 2001;
Bearden et al., 2001) and a high incidence of emotional problems
(Woodin et al., 2001) in childhood, and 30% of them develop
schizophrenia in adolescence or early adulthood (Pulver et al.,
1994). New 22q11.2 deletions account for 1%–2% of sporadic
schizophrenia cases (Xu et al., 2008). Most affected individuals680 Neuron 86, 680–695, May 6, 2015 ª2015 Elsevier Inc.carry a 3 Mb deletion, whereas 7% have a nested 1.5 Mb dele-
tion spanning 27 known genes.
Previous work has provided insights into the genetic basis of
the psychiatric and cognitive symptoms observed in carriers of
22q11.2 deletions and implicated a subset of these genes
including ZDHHC8 (Mukai et al., 2004). Notably, a genetic variant
of ZDHHC8 that modulates the complex splicing pattern at this
locus was associated with schizophrenia in some cohorts of
karyotypically normal patients (Mukai et al., 2004; Chen et al.,
2004). ZDHHC8 is a palmitoyltransferase belonging to a 23-
member family of enzymes that share a conserved cysteine-
rich signature catalytic domain (DHHC domain) (Fukata and Fu-
kata, 2010). Protein palmitoylation describes the addition of the
saturated 16-carbon palmitate lipid at specific cysteine residues
by a liable thioester bond (el-Husseini and Bredt, 2002) and has
emerged as a key reversible posttranslational protein modifica-
tion involved in the protein trafficking and the regulation of
diverse membrane and cytosolic proteins, especially in neurons
(el-Husseini and Bredt, 2002). The biochemical machinery
involved has only recently been identified, and our earlier work
established a connection between palmitoylation and neural
signaling in vivo (Mukai et al., 2008).
Using chromosomal engineering, we generated theDf(16)A+/
mouse model, which carries a 1.3 Mb chromosomal deficiency
(Df(16)A) that is syntenic to the human 22q11.2 1.5 Mb deletion
(Stark et al., 2008). We also reported the generation and charac-
terization of a mouse strain carrying a deletion of the Zdhhc8
gene (Mukai et al., 2004; Mukai et al., 2008). We have previously
shown that Df(16)A+/ mice have reduced dendritic branching
and spine density in hippocampal neurons, a phenotype, which
is also observed in Zdhhc8-deficient mice (Mukai et al., 2008).
We also provided evidence that PSD95, a key postsynaptic pro-
tein, is one of the substrates of ZDHHC8, a finding replicated
recently by Ho et al. (2011) and Yoshii et al. (2011).
As part of our systematic efforts to identify additional ZDHHC8
substrates, we made the unexpected discovery that Zdhhc8
deficiency affects palmitoylation of a number of proteins thought
to regulate axonal growth and branching. By following up this
finding, we present the results of a comprehensive analysis of
Figure 1. Acyl-Biotinyl Exchange Analysis
of Neuronal Protein Palmitoylation and
Axonal Alterations in Zdhhc8-Deficient
Cortical Neurons
(A) Palmitoylation levels of selected palmitoyl
protein candidate substrates. Proteins, ABE-puri-
fied from cultured cortical neurons from WT and
Zdhhc8/ mice, both in the presence (+) and
absence () of hydroxylamine (HA), were analyzed
by western blotting using the indicated specific
antibodies. Palmitoylated proteins are expected
to show HA-dependent detection. As a control,
a portion of the starting protein sample (prior to
ABE purification) was also screened. Palm, pa-
ralemmin; SYNT I, synaptotagmin I.
(B) Quantification of the palmitoylation changes
induced by Zdhhc8/ deficiency. Protein levels
measured from the purified palmitoyl-protein
samples were normalized to levels measured from
the corresponding input of substrates.
(C) Representative images of Zdhhc8-dependent
axonal deficits in cortical neurons expressing
EGFP at DIV4. Zdhhc8/ cortical neurons were
transfected with plasmids expressing EGFP and
ZDHHC8-FL or ZDHHC8-C134A at DIV2 and fixed
at DIV4. Scale bar, 50 mm.
(D) Quantification of axon length and branchpoint
number in Zdhhc8-deficient cortical neurons.
Transfection of ZDHHC8-FL, but not ZDHHC8-
C134A, restored axon length and branchpoint
number. Data are shown as means ± SEM. *p <
0.05; **p < 0.001; ***p < 0.0001; Student’s t test.
See also Figure S1.axonal projections of pyramidal neurons frombothDf(16)A+/ and
Zdhhc8-deficientmice.We found thatmutantmicehavedeficits in
axonal growth during embryogenesis as well as in terminal arbor-
ization,which can beprevented by reintroduction of enzymatically
active ZDHHC8. Impaired terminal arborization of pyramidal neu-
rons is accompanied by a reduction in the strength of synaptic
connections as well as altered functional connectivity and spatial
working memory (WM) performance. Finally, using genetic and
pharmacological rescue, we show that the effect of ZDHHC8 on
axon growth ismediated in part via Cdc42-dependentmodulation
of Akt/Gsk3b signaling at the tip of the axon. The palmitoylation-
dependent changes in structural connectivity we describe repre-
sent possible predisposing factors to thepsychiatric andcognitive
symptoms associated with the 22q11.2 deletion.
RESULTS
Palmitoyl-Proteome in Zdhhc8-Deficient Neurons
To find substrates of ZDHHC8 palmitoyltransferase activity, we
employed the acyl-biotinyl exchange (ABE) proteomic technol-Neuron 86, 680ogy (Wan et al., 2007), which purifies
palmitoylated proteins from complex pro-
tein extracts. Proteins extracted from
cultured mouse embryonic cortical neu-
rons from Zdhhc8/ and wild-type (WT)
mice at DIV21 were used for this analysis.We have previously shown that PSD95 is a ZDHHC8 substrate
(Mukai et al., 2008; Ho et al., 2011). Other proposed ZDHHC8
substrates include GAP43 (Mukai et al., 2008) and GRIP1
(Thomas et al., 2012). ABE analysis showed that, compared
with WT neurons, palmitoylation level of PSD95 was reduced
by 30% in Zdhhc8/ (Zdhhc8/, 22 mice, n = 22; Zdhhc8+/+,
21 mice, n = 21, p < 0.0003) (Figure 1A). GRIP1 was also reduced
26% in Zdhhc8/ (Zdhhc8/, 17 mice, n = 17; Zdhhc8+/+,
16 mice, n = 16, p < 0.005) (Figures 1A and 1B). Palmitoylation
of GAP43 was reduced by 17% in Zdhhc8/ neurons
(Zdhhc8/, 26 mice, n = 26; Zdhhc8+/+, 28 mice, n = 28, p <
0.001). In contrast, SNAP25 (Zdhhc8/, 112%, 17 mice, n =
17; Zdhhc8+/+, 16 mice, n = 16, p > 0.1) and Synaptotagmin I
(Zdhhc8/, 99%, 17 mice, n = 17; Zdhhc8+/+, 16 mice, n = 16,
p > 0.1), whichwere not palmitoylated by ZDHHC8 in vitro (Mukai
et al., 2008), showed no change of palmitoylation level in
Zdhhc8/ neurons as assayed by ABE. Having validated our
approach, we looked for additional substrates.
The strongest reduction of palmitoylation in Zdhhc8/ neu-
rons was observed for Rho GTPases, Cdc42 and Rac1, which–695, May 6, 2015 ª2015 Elsevier Inc. 681
regulate actin cytoskeleton and cellular morphology inducing fi-
lopodia and lamellipodia in many cell types (Iden and Collard,
2008), while in neurons they have been implicated in the regula-
tion of axonal development and cell polarity (Tahirovic et al.,
2010; Garvalov et al., 2007; Nishimura et al., 2005). In
Zdhhc8/ neurons, palmitoylation of Cdc42 was reduced by
33% (Zdhhc8/, 17 mice, n = 17; Zdhhc8+/+, 16 mice, n = 16,
p < 0.005), and palmitoylation of Rac1 was reduced by 38%
(Zdhhc8/, 17 mice, n = 17; Zdhhc8+/+, 16 mice, n = 16, p <
0.0001).
Zdhhc8 Deficiency Disrupts Axonal Growth
Our finding that ZDHHC8 palmitoylates a number of proteins
involved in axonal development prompted us to investigate the
role of Zdhhc8 in this process. To this end, we first used cortical
cultures from Zdhhc8-deficient mice (Zdhhc8+/, Zdhhc8/)
and Zdhhc8+/+ littermates (see Figure S1A available online).
Dissociated cortical neurons were cultured for 3 days, and
axon polarity was analyzed by staining with anti-Tau-1 antibody
as an axon-specific marker, anti- MAP2 antibody as a dendritic
marker, and phalloidin to visualize the whole neuron. Control
WT cortical neurons developed normal polarity, with most of
them having a single axon and multiple dendrites (77.0% ±
0.9%), 3.4% ± 0.5% of neurons with multiple axons, and
19.6% ± 1.2% of neurons with no discernable axon. Zdhhc8
deficiency significantly reduced the portion of neurons having
a single axon (Zdhhc8+/, 67.3% ± 1.3%, p < 0.0001;
Zdhhc8/, 62.1% ± 1.8%, p < 0.0001) (Figures S1A and S1B).
The axons of Zdhhc8-deficient neurons were also significantly
shorter than those of the WT cells (Figure S1C). The length and
number of dendrites were modestly, but significantly, reduced
in Zdhhc8-deficient neurons (Figures S1D and S1E).
To elaborate further on this observation, dissociated cortical
neurons were transfected with a plasmid for EGFP at DIV2 and
cultured for 4 days before analysis of axon length and branch-
ing. Primary axon length was reduced in Zdhhc8+/ and
Zdhhc8/ neurons at DIV4 (341.2 ± 14.6 mm, n = 24, p <
0.05; 305.2 ± 22.2 mm, n = 24, p < 0.005), compared to
Zdhhc8+/+ neurons (421.4 ± 17.1 mm, n = 24) (Figures 1C
and 1D). Specifically, Zdhhc8 deficiency caused a decrease
in the number of branch points in both Zdhhc8+/ (4.0 ± 0.3,
n = 24, p < 0.05) and Zdhhc8/ (3.3 ± 0.3, n = 24, p <
0.001) neurons compared to Zdhhc8+/+ neurons (5.3 ± 0.3,
n = 24; Figures 1C and 1D), respectively. To confirm that the
effect on axonal growth was directly mediated via ZDHHC8
transferase activity, we expressed the full-length enzymatically
active form (ZDHHC8-FL) or an enzymatically inactive form
(ZDHHC8-C134A) in cortical neurons from Zdhhc8/ mice.
In Zdhhc8/ neurons expressing ZDHHC8-FL (n = 24), the
numbers of total branchpoints (5.2 ± 0.3, n = 24, p < 0.05)
and primary axon length (397.0 ± 22.7, n = 24, p < 0.05)
were restored to Zdhhc8+/+ levels, whereas the enzymatically
inactive form (n = 18) did not influence these parameters (Fig-
ures 1C and 1D).
Prompted by these findings, we investigated further whether
palmitoylation in general regulates axon polarity. The conse-
quence of suppressing palmitoylation in developing neurons
was examined using 2-bromopalmitate (2-BP), an inhibitor to682 Neuron 86, 680–695, May 6, 2015 ª2015 Elsevier Inc.palmitoyltransferase activity, to treat cultured cortical neurons
during the transition from stage 2 to stage 3, a critical period in
which rapid axonal growth and polarization occur (Yoshimura
et al., 2006). While most WT cells displayed a single neurite
marked by the axonal marker Tau-1 (78.0% ± 0.5% of the
cells), treatment with 2-BP reduced neurons with a single
Tau-1-positive neurite (to 56.0% ± 1.1% of cells treated with
0.1 mM 2-BP) (Figures S1F and S1G). Both axons (Figures
S1F and S1H) and MAP2-stained dendrites (Figures S1I and
S1J) of treated cells were significantly shorter (in a dosage-
dependent manner) than that of untreated cells. In addition,
analysis of axon branching at DIV4 (following treatment with
0.1 mM 2-BP) revealed a reduction in primary axon length
compared to control neurons (288.0 ± 11.2 mm versus
432.5 ± 23.9 mm, n = 18, p < 0.001) as well as a significant
decrease in the number of branchpoints compared to control
neurons (2.3 ± 0.2 mm versus 5.8 ± 0.5 mm, n = 18, p <
0.005) (Figures S1M–S1P). Interestingly, 0.1 mM 2-BP treat-
ment further reduced the portion of Zdhhc8/ single-axon
cells compared to untreated Zdhhc8/ cells (49.8% ± 2.2%
versus 62.0% ± 1.8%, Figures S1K and S1L), suggesting
that other DHHC isoforms might also contribute to modulate
neuronal polarity.
ZDHHC8 Activity Is Required for Axon Growth In Vivo
To determine the effect of ZDHHC8 activity on axon develop-
ment in vivo, we used in utero electroporation to express
EGFP in newly divided cortical neurons of Zdhhc8/ embryos
and examine axon morphology at a single-cell resolution (Fig-
ure S2A). Following electroporation at E14.5, embryos were
placed back into the mother and allowed to develop for an
additional 3 days (E17.5), at which point the morphology of
EGFP-positivemigrating neuronswas examined. Electroporated
neurons in both control and mutant cortices had migrated
through the intermediate zone (IZ) and reached the cortical plate
(CP) (Figure S2A), indicating that ZDHHC8 is dispensable for
proper radial migration.
When neuronal migration through the CP is completed, trans-
fected layers 2/3 neurons show a polarized morphology with
developing dendritic arbors and thin, straight axons. In WT
brains, EGFP-expressing neurons show a typical basal axon
and multiple apical dendrites derived from a single dendritic
base (Figures S2B and S2C). The vast majority of both WT and
mutant neurons have a single axon. Although we cannot exclude
subtle polarity differences among genotypes, Zdhhc8 deficiency
does not appear to have a strong effect on polarity in vivo. This
likely relates to the redundancy of DHHC palmitoyltransferases
and polarity signaling pathways. On the other hand, examination
of the length of axons in WT or Zdhhc8-deficient cortices
confirmed that Zdhhc8 deficiency resulted in a decrease in
axon length (11% in Zdhhc8+/ [n = 24, p < 0.05], 25% in
Zdhhc8/ [n = 24, p < 0.001]) compared with Zdhhc8+/+ brains
(n = 24) (Figures S2B and S2C). Expression of ZDHHC8 FL (n =
18) restored axonal length in Zdhhc8/ brains to Zdhhc8+/+
levels (Figures S2B and S2C).
To investigate further the role of ZDHHC8 on axonal branch-
ing, plasmids encoding EGFP were electroporated in utero into
the dorsolateral ventricular zone of the mouse forebrain at
E15.5, and embryos were allowed to be born and develop to
P8.5 for analysis. All cells labeled with EGFP completed their
migration into layers 2/3 by P8.5. As shown previously (Jeanne-
teau et al., 2010), callosal axons crossed the midline, coursed
beneath the gray matter of the contralateral somatosensory cor-
tex, penetrated the gray matter, and ascended to layers 1–3 and
5 (Figure 2A).
The number of callosal axon-terminal branches within the
contralateral cortical layers 1–4 was decreased by disruption
of Zdhhc8, with notably fewer secondary branches (total
branch number, 34% in Zdhhc8+/ [n = 19, p < 0.0001], 45% in
Zdhhc8/ [n = 19, p < 0.0001]), comparedwith Zdhhc8+/+ brains
(n = 19) (Figures 2B, 2D, and 2E). Analysis of the collateral
branching of axons within the ipsilateral cortical layers 2–4 (Fig-
ures 2C and 2F) showed that disruption of Zdhhc8 resulted in a
decrease in the number of axonal branches (23% in Zdhhc8+/
[n = 19, p < 0.001], 31% in Zdhhc8/ [n = 19, p < 0.0001])
compared with Zdhhc8+/+ brains (n = 19) (Figure 2G). To confirm
that the effect on axonal branching was directly mediated
via ZDHHC8 activity, we electroporated a construct driving
both EGFP and ZDHHC8FL (ZDHHC8FL::IRES-EGFP) into
Zdhhc8/ embryos in utero. Restricting our analysis to ipsilat-
eral projections, we showed that ZDHHC8FL expression re-
versed the number of axonal branches in cortical layers 2–4 to
WT levels (Figures 2H and 2I).
To examine whether reduced axonal arborization persists in
adulthood, mice were electroporated with EGFP at E15.5 and
weresacrificedatP56 toevaluateadult patternsof axonalbranch-
ing. As shown previously in P21 brain (Courchet et al., 2013),
callosal axons of layers 2/3 pyramidal neurons branch extensively
between P8.5 and P56 in contralateral layers 1–3 and layer 5 (Fig-
ures S2D and 2J) and ipsilateral layers 2/3 and layer 5 (Figure 2K)
while avoiding branching in layers 4 and 6 both contralateral and
ipsilateral hemispheres. We analyzed EGFP intensity in ipsilateral
and contralateral axon target regions to quantify the complexity
of axon branching. Zdhhc8 deficiency showed significantly
reduced branching contralaterally in both layer 1 and 2/3 (Fig-
ure 2J) as well as ipsilaterally in layer 5 (Figure 2L).
Zdhhc8Deficiency Disrupts Hippocampal Projections to
mPFC and WM Performance
We have previously shown that 22q11.2 deletion lead to
abnormal PFC–HPC coupling, similar to the one reported in
schizophrenia patients (Sigurdsson et al., 2010). Such long-
range connectivity deficits may underlie deficits in cognition
and other aspects of the clinical diagnosis. We have also re-
ported an impairment of spatial WM in Df(16)+/mice, which ap-
pears to be due in part to altered functional connectivity between
the HPC andmPFC (Sigurdsson et al., 2010). The circuit basis for
this deficit may be complex, involving at least in part anatomical
connections affected in terms of axonal extension and branch-
ing. We therefore asked whether Zdhhc8 deficiency disrupts
the long-range projection from the HPC to mPFC and affects
HPC-mPFC synchrony and WM performance.
Initial analysis of axonal morphogenesis in primary hippocam-
pal neurons collected from Zdhhc8-deficient mice and their WT
littermates revealed a deficit of polarity as well as a pattern and
degree of axonal arbor simplification (Figures S3A–S3I) verysimilar to those observed in Zdhhc8-deficient cortical neurons.
Most importantly, deficits observed in vitro in neuronal cultures
are recapitulated in the developing brains of mutant mice.
Following in utero electroporation of an EGFP construct to
ventral hippocampus (vHPC) at E16.5 (Figure S3J), the
morphology of EGFP-positive axons was examined in sagittal
brain sections during postnatal development. Labeled ventral
field CA1axons in both Zdhhc8+/+ and Zdhhc8+/ projected nor-
mally to frontal regions of the cerebral cortex, extended rostrally
through the lateral septal nucleus in the precommissural fornix,
and reached the dorsal tenia tecta. At P16.5 a subset of fibers
at the tenia tecta extended dorsally near the genu of the corpus
callosum to the infralimbic area, prelimbic area, and anterior cin-
gulated area (Figure S3J). At P16.5 the number of axon-terminal
branches in the layer 5 of prelimbic mPFC was significantly
reduced in Zdhhc8+/ mice, with notably fewer secondary
branches (Figures S3K and 3A–3C). To examine whether
reduced axonal arborization persists in adulthood, we injected
an adeno-associated virus (rAAV1/hSynapsin/EGFP) into CA1
in the vHPC at P56 (8 weeks), and mice were sacrificed at P84
(12 weeks) (Figure S3L). Evaluation of patterns of axonal branch-
ing in mPFC of Zdhhc8-deficient mice showed significantly
reduced axon branching in layer 5 of prelimbic mPFC (Figures
3D–3F).
To examine the impact of Zdhhc8 deficiency on long-range
functional connectivity and WM, Zdhhc8+/ mice and their WT
littermates were implanted with recording electrodes aimed at
the ventral (vHPC) and dorsal hippocampus (dHPC), as well as
the medial prefrontal cortex (mPFC). Neural activity was then re-
corded at baseline, and during training and testing in the T-maze
delayed nonmatch to sample test of spatial WM. Behaviorally,
Zdhhc8+/ mice took significantly longer than WT mice to reach
criterion performance on the T-maze task (Figure 3G). Zdhhc8+/
mice also showed lower theta-frequency (4–12 Hz) coherence
between vHPC and mPFC as well as vHPC and dHPC after
acquisition of the task (Figures 3H–3K). Although there was no
statistically significant difference in theta coherence during a
baseline session before training (Figure 3L), baseline theta
coherence between vHPC and mPFC was inversely correlated
with days to criterion (Figure 3M). Thus, the observed deficits
in anatomical connectivity between vHPC and mPFC, due to
Zdhhc8 deficiency, are accompanied by a disruption of func-
tional connectivity between these two areas during behavior,
which was narrower than that seen with the complete mutation
(Df16(A) +/ mice; Sigurdsson et al., 2010). In turn, disruption of
the long-range projections from HPC to mPFC may contribute,
possibly along with more localized deficits in pyramidal and
inhibitory neuron function, to the impaired WM performance.
Disrupted Axonal Growth and Branching in Df(16)A+/–
Mice
In addition to the impaired connectivity between vHPC and
mPFC, several other salient features identified by our analysis
of Zdhhc8-deficient mice were recapitulated in Df(16)A+/mice.
First, ABE analysis showed that, compared with WT neurons,
palmitoylation level of PSD95, Cdc42, and Rac1 was reduced in
Df(16)A+/ (Figures S4A and S4B), but to a lesser extent than in
Zdhhc8/ (Figures 1A and 1B).Neuron 86, 680–695, May 6, 2015 ª2015 Elsevier Inc. 683
Figure 2. Downreguration of Zdhhc8 Disrupts Axonal Growth In Vivo
(A) Illustration of the callosal axon pathway of neurons residing at layers 2/3, electroporated with EGFP at E15.5 and assayed at P8.5 (upper panel). Lower panel
shows EGFP-labeled neurons.
(B andC) Representative images of contralateral axon-terminal branching (B) and ipsilateral axon branching (C) of EGFP-labeled neurons from coronal sections of
P8.5 brains of mice in utero electroporated at E15.5. Representative images are composites of more than one image acquired from one brain section under
identical scanning parameters. Image merging planes are indicated by white dots at the side of each panel.
(legend continued on next page)
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Second, analysis of axonal morphogenesis in primary
cortical neurons from Df(16)A+/ mice and their WT littermates
revealed a pattern and degree of axonal arbor simplification
very similar to those observed in Zdhhc8 deficient neurons.
Specifically, compared to DIV3 WT neurons, Df(16)A+/ neu-
rons demonstrated a significantly reduced portion of single
axon cells (66.0% ± 1.0% versus 78.0% ± 1.0% in WT, p <
0.0001; Figures S4C and S4D). Also, the axons of Df(16)A+/
neurons were significantly shorter than those of the WT cells
(78.1 ± 3.0 mm versus 116.2 ± 3.0 mm in WT, p < 0.0001; Fig-
ure S4E). The length and number of dendrites were also
significantly reduced in Df(16)A+/ neurons (Figures S4F and
S4G) at DIV3.
At DIV4, when axon branching ensues, primary axon length
was reduced in Df(16)A+/ neurons compared to WT neurons
(323.3 ± 13.0 mm versus 409.3 ± 23.7 mm, n = 24, p < 0.05;
Figures S4H and S4I), and there was a decrease in the
number of branchpoints compared to WT neurons (4.16 ± 0.2
versus 5.6 ± 0.5, n = 24, p < 0.05; Figures S4H and S4J). Intro-
duction of ZDHHC8 FL confirmed that the reduction in axonal
complexity was a direct effect of reduced ZDHHC8 activity (Fig-
ures S4H–S4K).
Deficits observed in vitro in neuronal cultures are recapitulated
in the developing brain of Df(16)A+/ mice, where again the
pattern and degree of axonal arbor simplification were very
similar to those observed in Zdhhc8-deficient mice. Following
in utero electroporation of an EGFP construct at E14.5,
Df(16)A+/ embryos were placed back into the mother and
allowed to develop for an additional 3 days (E17.5). Electropo-
rated neurons in both WT and Df(16)A+/ had normally migrated
through the IZ and reached the CP (Figure S4L). Presence of
Df(16)A resulted in a 20% decrease in length of axon, located
in layers 2/3 (n = 31, p < 0.0001), compared withWT (n = 24) (Fig-
ures S4M and S4N). Df(16)A also resulted in decrease in both
ipsi- and contralateral axonal branching at P8.5 (Figures 4A–
4F). Introduction of ZDHHC8 FL restored axon length (Figures
S4M and S4N) and axon branching (Figures 4G and 4H) in
Df(16)A+/ brain to WT levels. By contrast, introduction of
PRODH, one of the deleted genes resting within Df(16)A that(D) Tracings of representative neurons in in utero electroporated brains expressing
axon terminal in the contralateral cortical layers 1–4. Primary (blue), secondary (r
20 mm.
(E) Quantitative assessment of contralateral axon branching in layers 1–4 reveals
(F) Tracings of representative neurons in in utero electroporated brains expressing
axon branching in the ipsilateral cortical layers 2–4. Primary (blue) branches from
(G) Quantification of axon branch numbers in the ipsilateral layers 2–4 reveals a
(H) Tracings of representative neurons, depicting 2D projection of the ipsilateral a
EGFP vector (Zdhhc8/ and WT mice) or ZDHHC8FL::IRES-EGFP (Zdhhc8/ m
(I) Quantification of axonal branch numbers in the ipsilateral layers 2–4, el
ZDHHC8FL::IRES-GFP (Zdhhc8/ mice). ZDHHC8-FL restored axonal branch n
(J) Representative images of contralateral axon-terminal branching of EGFP-label
at E15.5 (left panel). Right panel depicts a quantitative assessment of contralatera
of branch number in layers 1 and 2/3 in Zdhhc8+/ mice (n = 25, six brains), com
(K) Representative images of ipsilateral axon branching of EGFP-labeled neurons f
both (J) and (K), representative images are composites of more than one image
merging planes are indicated by white dots at the side of each panel.
(L) Quantitative assessment of ipsilateral axon branching in layer 5 at P56 reveals
to Zdhhc8+/+ mice (n = 24, five brains).
Data are shown as means ± SEM. *p < 0.05; **p < 0.001; ***p < 0.0001; Studenthas a well-defined function not related to protein palmitoylation,
did not influence these parameters.
To examine whether reduced axonal arborization persists in
adulthood, Df(16)A+/ mice were electroporated with EGFP at
E15.5 and were sacrificed at P56 to evaluate adult patterns of
axonal branching. Df(16)A+/ showed significantly reduced
branching contralaterally both in layer 1 and 2/3 (Figure 5A)
and ipsilaterally in layer 5 (Figures 5B and 5C). To assesswhether
a decrease in axonal branching of layer 2 pyramidal neurons was
associated with a deficit in synaptic efficacy in L2–L5 neurons,
we employed an optogenetic approach, in which a vector driving
ChR2-Venus together with mCherry was delivered to L2 neurons
by in utero electroporation at E16.5 (Figure 5D). Using acute cor-
onal brain slices prepared from the frontal cortex of 8-week-old
mice, we then performed extracellular recordings ipsilateral to
the electroporated hemisphere (Figure 5E). Optical stimulation
of the fibers and terminals of the transfected L2 neurons (ex-
pressing ChR2) triggered neurotransmitter release recorded as
field EPSPs (fEPSPs) in L5 (Figures 5E and 5F). At higher stimu-
lation intensities, the optically evoked fEPSPs were smaller in the
Df(16)A+/ mice (n = 5, n = 11) compared to their WT littermates
(n = 7, n = 16) (Figure 5G, stimulation intensities 3–10, p < 0.05).
To rule out the possibility that the observed difference in the
input-output curve between genotypes could be due to different
ChR2 expression in the activated axons, the input-output curves
were normalized, and their similitude suggests that ChR2 levels
were comparable in each group of activated axons (Figure S5A,
p > 0.05). It is known that the size of evoked fEPSPs depends on
the number of synapses and on the probability of neurotrans-
mitter release. In addition, the probability of vesicular release
has been shown to be inversely proportional to the ratio of
fEPSPs obtained using paired-pulse stimulation. Therefore, we
performed paired-pulse stimulation to determine whether the
differences in synaptic strength at higher stimulation intensities
were due to differences in the probability of neurotransmitter
release at the layer 2–5 synapses between genotypes. Light-
evoked PPR was normal in Df(16)A+/ mice at a variety of inter-
stimulus intervals (Figure S5B, two-way repeated-measures
ANOVA; p > 0.05), suggesting that the different fEPSPsEGFP at P8.5, from similar sections as in (B). Depicted are 2D projections of the
ed), and tertiary (pink) branches from axons (green) are highlighted. Scale bar,
a reduction of branch number in Zdhhc8-deficient mice.
EGFP at P8.5, from similar sections as in (C). Depicted are 2D projections of the
axon (green) and soma (gray) are highlighted. Scale bar, 20 mm.
reduction of branch number in Zdhhc8-deficient mice.
xonal arbor in layers 2–4 from brains in utero electroporated with either IRES-
ice). Scale bar, 20 mm.
ectroporated with either IRES-EGFP vector (Zdhhc8/ and WT mice) or
umbers in the ipsilateral layers 2–4 of Zdhhc8/ mice.
ed neurons from coronal sections of P56 brains of mice in utero electroporated
l axon branching in layers 1–6 and the white matter at P56 indicating a reduction
pared to Zdhhc8+/+ mice (n = 20, five brains).
rom coronal sections of P56 brains ofmice in utero electroporated at E15.5. For
acquired from one brain section under identical scanning parameters. Image
a reduction of branch number in Zdhhc8+/mice (n = 24, six brains), compared
’s t test. See also Figure S2.
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Figure 3. Zdhhc8 Haploinsufficiency Impairs Spatial Working Memory and Prefrontal-Hippocampal Synchrony
(A) Tracings of representative vHPC neurons from Zdhhc8mouse brains (Figure S3J), in utero electroporated an EGFP construct to vHPC at E16.5, depicting 2D
projection of the axon terminal in the prelimbic layer 5 at P16. Primary (blue), secondary (red), and tertiary (pink) branches from axons (green) are highlighted. Scale
bar, 50 mm.
(B) Quantitative assessment of vHPC axon branching in prelimbic layer 5 results in a reduction of branch number in Zdhhc8+/mice (p < 0.05, n = 18, six animals),
compared to Zdhhc8+/+ mice (n = 18, five animals). Graph showing the proportion of branches of different order in axon arbors.
(legend continued on next page)
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amplitudes reflect differences in the number of functional synap-
ses probably due to the decrease in axonal branching of layer 2
pyramidal neurons of Df(16)A+/ mice.
Signaling Pathways as Downstream Effectors of
ZDHHC8 in Mediating Axonal Growth
Several of the ZDHHC8 substrates represent downstream effec-
tors that could mediate the biological activity of ZDHHC8
on axon growth and branching. We focused on the reduction
of palmitoylated Cdc42 in Zdhhc8-deficient neurons (Figure 1),
given the well-established role of Cdc42 in axonal development
and the fact that alterations in Cdc42 expression have been
consistently reported in the brains of patients with psychiatric
disorders, including schizophrenia (Gilks et al., 2012; Ide and
Lewis, 2010). Genetic ablation of Cdc42 leads to deficits in
neuronal polarity and elongation of axons in cultured hippocam-
pal neurons as well as in cortical neurons in vivo (Garvalov et al.,
2007; Nishimura et al., 2005), suggesting that Cdc42 may
contribute to the axonal phenotypes emerging as a result
of the Zdhhc8 deficiency. Alternative splicing gives rise to
two different Cdc42 isoforms: a ubiquitously expressed can-
onical form (isoform 1) and a brain-specific form (isoform 2,
Cdc42Palm) (Nishimura and Linder, 2013). Canonical Cdc42
carries a CaaX motif (prenylation) at its C-terminal (CVLL),
whereas Cdc42Palm carries a double-cysteine CCaX (CCIF)
motif. Cdc42Palm is palmitoylated, whereas the canonical
form is not (Nishimura and Linder, 2013; Kang et al., 2008). Wirth
et al. (2013) reported that the expression level of Cdc42Palm
in the hippocampus was approximately 2-fold higher than that
of isoform 1. We specifically examined the involvement of
Cdc42Palm in axonal growth.
Exogenous Cdc42Palm fused to EGFP (EGFP- CDC42Palm) is
enriched at the axon tip at DIV3 (Figure S6A), whereas a mutant
form with disrupted palmitoylation sites (EGFP-C2S) is diffusely
localized in the entire cell (Figure S6A). A specific antibody
against Cdc42Palm showed an enrichment of the endogenous
Cdc42Palm at tip of axon (Figure 6A). 2-BP treatment disrupts
this enrichment and diffusely disperses Cdc42Palm to entire
cell (Figure S6B). These findings indicate that palmitoylation
results in targeting and transporting Cdc42Palm to the tip of
the axon, where it modulates axonal length and branching.
Compared with WT neurons (n = 64), the normalized intensity
of the endogenous Cdc42Palm at the tip of axons is decreased(C) Total branch number in prelimbic layer 5 results in a reduction of branch numbe
(n = 18, five animals).
(D) Tracings of representative vHPCneurons from Zdhhc8mouse brains (Figure S3
the axon terminal in the prelimbic layer 5 at P84 (12 weeks). Primary (blue), second
bar, 20 mm.
(E) Quantitative assessment of vHPC axon branching in prelimbic layer V results in
compared to Zdhhc8+/+ mice (n = 20, four animals). Graph showing the proportio
(F) Total branch number in prelimbic layer 5 results in a reduction of branch numbe
(n = 20, 4 animals).
(G) Days taken to reach criterion performance (3 consecutive days of >70% cho
(H–K) Averaged coherence spectra between each pair of brain regions, vHPC-m
acquisition of the task. Shaded areas are ± SEM (H–J). Theta-frequency coheren
(L) Baseline theta coherence between each pair of regions during habituation be
(M) Relationship between days to criterion and baseline theta coherence betwee
**p < 0.01; Student’s t test. Data are means ± SEM. See also Figure S3.by 19% and 28% in the Zdhhc8+/ (n = 64, p < 0.02) and
Zdhhc8/ (n = 67, p < 0.001) neurons, respectively (Figures
6A and 6B), whereas the area of axon tip displayed no signifi-
cant change among genotypes (Figure S6C). Reciprocally,
Cdc42Palm abundance at axon shafts was increased by 2.1
and 2.9 times in the Zdhhc8+/ (n = 64, p < 0.0001) and
Zdhhc8/ (n = 67, p < 0.0001) neurons, respectively, compared
with WT littermates (n = 64) (Figure 6C). Thus, Zdhhc8 deficiency
disrupts the subcellular localization of Cdc42Palm.
To examine the role of endogenous Cdc42Palm in axonal
development, an EGFP plasmid-based short hairpin RNA
(shRNA) targeting Cdc42Palm was electroporated ex utero into
E15.5 embryos. We immediately dissected cortices and estab-
lished primary neuronal cultures to analyze neuronal polarity
at DIV3 (Figures S6D and S6E) and axon branching and length
at DIV4 (Figures 6D–6G). Whereas most cells (71%) have a sin-
gle axon in control scrambled shRNA-transfected neurons,
Cdc42Palm knockdown displayed a decrease in cells having a
single axon (42%, p < 0.0001) (Figures S6D and S6E). The axons
of Cdc42Palm knockdown neurons were significantly shorter
than those of the control cells (60.3 ± 3.9 mm versus 112.1 ±
6.0 mm in WT, p < 0.0001; Figure S6F). The length and number
of dendrites were also significantly reduced in Cdc42Palm
knockdown neurons (Figures S6G and S6H) at DIV3.
In addition, Cdc42Palm knockdown yielded significant reduc-
tions of primary axon length (225.3 ± 9.4 mm; n = 32, p < 0.001),
axon branching (2.0 ± 0.3; n = 32, p < 0.01), and total axon length
(354.8 ± 26.2 mm; n = 32, p < 0.01) compared to scrambled
shRNA controls (primary axon length, 364.4 ± 26.2 mm; axon
branching, 3.8 ± 0.5; total axon length, 545.3 ± 47.9 mm; n =
24) at DIV4 (Figures 6D–6G).
To determine the role of Cdc42Palm on axon development
in vivo, we used in utero electroporation of an shRNA targeting
Cdc42Palm in newly divided neurons. Following electroporation
at E14.5, axonal morphology of neurons was quantified at E17.5.
Knockdown of Cdc42Palm resulted in a decrease in axon length
(24%, n = 30, p < 0.0001) compared with scrambled control
shRNA (n = 33) (Figures S6I and S6J). Axon branches in the ipsi-
lateral cortical layers 2–4 in P8.5 brain sections were also quan-
tified, following in utero electroporation of the shRNA at E15.5
(Figures 6H and 6I). Cdc42Palm knockdown resulted in a
decrease in the number of axonal branches (30%, n = 18, p <
0.0001) compared with scrambled control shRNA (n = 18)r in Zdhhc8+/mice (p < 0.05, n = 18, six animals), compared to Zdhhc8+/+mice
L), injected rAAV1/hSynapsin/EGFP to vHPCat P56, depicting 2Dprojection of
ary (red), and tertiary (pink) branches from axons (green) are highlighted. Scale
a reduction of branch number in Zdhhc8+/mice (p < 0.05, n = 20, four animals),
n of different order branches in axon arbors.
r in Zdhhc8+/mice (p < 0.001, n = 20, 4 animals), compared to Zdhhc8+/+mice
ice accuracy) on the delayed non-match to sample T-maze task.
PFC (H), vHPC-dHPC (I), and dHPC-mPFC (J), during the choice phase after
ce by genotype for each region pair (K).
fore training.
n vHPC and mPFC. n = 8 and 9 animals for WT and Zdhhc8+/mice. *p < 0.05,
Neuron 86, 680–695, May 6, 2015 ª2015 Elsevier Inc. 687
Figure 4. Axonal Growth Is Disrupted in Df16(A)+/– Mice
(A) Confocal images of contralateral axon-terminal branching of EGFP-labeled neurons from coronal sections of P8.5 brains of mice in utero electroporated at
E15.5. Representative images are composites of more than one image acquired from one brain section under identical scanning parameters. Image merging
planes are indicated by white dots at the side of each panel.
(B) Tracings of representative neurons from similar sections as in (A), depicting 2D projection of the axon terminal in the contralateral cortical layers 1–4 from in
utero electroporated brains expressing EGFP at P8.5. Primary (blue), secondary (red), and tertiary (pink) branches from axons (green) are highlighted.
(C) Quantification of contralateral axon-terminal branch numbers in layers 1–4 reveals a reduction of branch number in Df16(A) +/ (n = 33, five brains), compared
to control mice brains (n = 22, six brains).
(D) Confocal images of ipsilateral axon branching of EGFP-labeled neurons from coronal sections of P8.5 brains of mice in utero electroporated at E15.5.
Representative images are composites of more than one image acquired from one brain section under identical scanning parameters. Image merging planes are
indicated by white dots at the side of each panel.
(E) Tracings of representative neurons in in utero electroporated brains expressing EGFP at P8.5, from similar sections as in (D). Depicted are 2D projections of the
axon branching in the ipsilateral cortical layers 2–4.
(F) Quantification of axon branch numbers in the ipsilateral layers 2–4 reveals a reduction of branch number inDf16(A) +/ (n = 18, five brains), compared to control
mice brains (n = 18, six brains).
(G) Tracings of representative neurons, depicting 2D projection of the ipsilateral axonal arbor in layers 2–4 from brains in utero electroporated with either IRES-
EGFP vector (Df16(A)+/ and WT mice) or ZDHHC8FL::IRES-EGFP (Df16(A)+/ mice) or PRODH::IRES-EGFP (Df16(A)+/ mice).
(H) Quantification of axonal branch numbers in the ipsilateral layers 2–4 of brains electroporatedwith either IRES-EGFP vector (Df16(A) +/ [n = 18, four brains] and
WT mice [n = 18, five brains]) or ZDHHC8FL::IRES-GFP (Df16(A)+/ mice [n = 18, four brains]), or PRODH::IRES-EGFP (Df16(A) +/ mice [n = 30, four brains]).
ZDHHC8-FL restored axonal branch numbers in the ipsilateral layers 2–4 in Df16(A)+/ mice.
Data are shown as means ± SEM. *p < 0.05; **p < 0.001; ***p < 0.0001; Student’s t test. See also Figure S4.(Figures 6H and 6I). These results suggest that Cdc42Palmmod-
ulates neuronal polarity, axonal elongation, and branching.
ZDHHC8 Regulates AKT/GSK3 Signaling
Three major classes of Cdc42 effectors include N-WASP (neu-
ral Wiskott-Aldrich syndrome protein); PAK (p21-activated ki-688 Neuron 86, 680–695, May 6, 2015 ª2015 Elsevier Inc.nases), which regulates actin polymerization and stabilization;
and PAR (partitioning-defective) proteins, which modulate the
PI3K/Akt/Gsk3 signaling pathway and regulate neuronal polar-
ity, axon extension, and branching by transducing upstream
signals to reorganization of axonal microtubules (Iden and
Collard, 2008).
Figure 5. Disrupted Axonal Branching and Synaptic Transmission in the Adult Brain of Df16(A)+/– Mice
(A) Representative images of contralateral axon-terminal branching of EGFP-labeled neurons from coronal sections of P56 (8 weeks) brains of mice in utero
electroporated at E15.5 (left panel). Representative images are composites of more than one image acquired from one brain section under identical scanning
parameters. Image merging planes are indicated by white dots at the side of each panel. Right panel depicts that a quantitative assessment of contralateral axon
branching in layers 1–6 and white matter at P56 indicating a reduction of branch number in layers 1 and 2/3 in Df16(A) +/mice (n = 18, four brains), compared to
WT mice (n = 20, five brains).
(B) Representative images of ipsilateral axon branching of EGFP-labeled neurons from coronal sections of P56 (8 weeks) brains of mice in utero electroporated at
E15.5. Representative images are composites of more than one image acquired from one brain section under identical scanning parameters. Image merging
planes are indicated by white dots at the side of each panel.
(C) Quantitative assessment of ipsilateral axon branching in layer 5 at P56 reveals a reduction of branch number inDf16(A)+/mice (n = 18, four brains), compared
to WT mice (n = 18, five brains).
(D) Confocal image of ChR2-Venus expressing neurons residing in the layer 2 from in utero electroporated brains at 8weeks. Representative image is a composite
of more than one image acquired from one brain section under identical scanning parameters. Image merging planes are indicated by white dots at the side of
each panel.
(E) Schematic drawing illustrating a coronal section of the mouse frontal cortex, in utero electroporated ChR2-Venus with mCherry to layer 2 neurons. Extra-
cellular electrophysiological recordings were performed at the ipsilateral layer 2–5 synapses.
(F) Pulses of blue light (488 nm) were used to evoke fEPSPs that were quantified bymeasuring the initial slope. Examples traces of light-evoked fEPSPs are shown
for both genotypes at photostimulation of increasing intensity.
(G) Summary of the optically-evoked fEPSPs at layer 2–5 synapses in the frontal cortex of WT (N = 7, n = 16; black squares) andDf(16)A+/mice (N = 4, n = 11; red
circles) at different stimulation intensities. The fEPSP of Df(16)A+/ mice are smaller at higher stimulations intensities (3–10 mWatts, p < 0.05).
See also Figure S5.The phosphatidylinositol 3-kinase (PI3K) signaling cascade is
necessary for axonal growth during polarization (Shi et al.,
2003). PI3K activates Akt by phosphorylation at Thr-308 and
Ser-473 via PIP3 phosphoinositide-dependent kinase (Yoshi-
mura et al., 2006). Activated Akt phosphorylates Gsk3b at
Ser-9 and inactivates its kinase activity (Yoshimura et al.,
2006). Inactivation of Gsk3b is necessary for efficient axon elon-
gation (Zhou et al., 2004). During neuronal polarization, both
PI3K and Akt are selectively transported to and enriched at the
tip of individual neurites, signaling the progression from nonpo-larized stage 2 to polarizing stage 3 (Shi et al., 2003). Localized
activation of Cdc42 at the leading edge recruits the Par3-Par6-
PKCz polarity complex, leading to Rac/PI3K activation (Nishi-
mura et al., 2005), or directly binds to the p110b catalytic subunit
isoform of PI3K, resulting in increased kinase activity and down-
stream Akt phosphorylation (Fritsch et al., 2013).
We electroporated an shRNA targeting Cdc42Palm ex utero
into E15.5 embryos and immediately dissected cortices and es-
tablished primary neuronal cultures (Figure 7A). Quantification
confirmed that Cdc42Palm knockdown significantly reducedNeuron 86, 680–695, May 6, 2015 ª2015 Elsevier Inc. 689
Figure 6. Zdhhc8 Deficiency Disrupts Tip Localization of CDC42Palm
(A) Representative images of DIV3 cortical neurons from Zdhhc8-deficient mice, immunostained for CDC42Palm (red) and phalloidin (green).
(B and C) Quantification of endogenous CDC42Palm fluorescent intensity in DIV3 Zdhhc8-deficient neurons reveals a reduction at the tip of axon (B) and a
reciprocal increase at the axon shaft (C).
(D) Tracings of representative neurons imaged at DIV4 following ex utero electroporation of an shRNA targeting CDC42Palm or a control scrambled shRNA. Scale
bar, 20 mm.
(E–G) Quantification of axon morphology reveals that knockdown of CDC42Palm results in a shortened axon and decreased branches.
(H) Tracings of representative neurons from coronal sections of C57 brains at P8.5, in utero electroporated with an shRNA targeting CDC42Palm or a control
scrambled shRNA at E15.5, depicting 2D projection of the axon branching in the ipsilateral cortical layers 2–4. Scale bar, 20 mm.
(I) Quantification of axon branch numbers in the ipsilateral layers 2–4 reveals that knockdown of CDC42Palm results in a reduction of branch numbers.
Data are shown as means ± SEM. *p < 0.05; **p < 0.001; ***p < 0.0001; Student’s t test. See also Figure S6.axon-tip intensity of pAkt (33%, n = 24, p < 0.001), compared to
control neurons (n = 24) (Figure 7B). As expected, axon-tip inten-
sity of pGsk3b (36%, n = 30, p < 0.05) was also reduced by the
Cdc42 Palm knockdown (Figures 7C and 7D).
We then asked whether Zdhhc8 deficiency disrupts the sub-
cellular localization of PI3K, pAkt, and pGsk3b. In stage 3 neu-
rons, Zdhhc8 deficiency resulted in a slight decrease in pAkt
staining within the soma (16%, n = 20, p < 0.05) (Figures 7E
and 7F). pAkt staining intensity at tip of axon was also decreased
by 13% and 24% in the Zdhhc8+/ (n = 20, p < 0.05) and
Zdhhc8/ (n = 20, p < 0.005) neurons, respectively, compared
with WT neurons (n = 20) (Figures 7E and 7F). Similarly, pGsk3b
intensity at the tip of axonswas also decreased by 14%and 25%690 Neuron 86, 680–695, May 6, 2015 ª2015 Elsevier Inc.in the Zdhhc8+/ (n = 20, p < 0.05) and Zdhhc8/ (n = 20, p <
0.003) neurons, respectively, compared with WT neurons (n =
20) (Figures 7G and 7H). Taken together, our results suggest
that ZDHHC8 is required for optimal Akt/Gsk3b signaling at the
tip of the growing axons and that this effect is mediated at least
in part via palmitoylation and axonal tip enrichment of Cdc42.
Notably, altered phosphorylation of Akt and Gsk3b is also
evident in western blot assays of PFC lysates of 8-week-old
Zdhhc8-deficient mice. pAkt (Ser473), a marker for Akt activa-
tion, was reduced 18% and 22% in the PFC of Zdhhc8+/
(6 mice, n = 18, p < 0.05) and Zdhhc8/ (6 mice, n = 18, p <
0.005), respectively, as compared with WT littermates (six
mice, n = 18) (Figures 8A and 8B). pGsk3b (Ser9) was reduced
Figure 7. Zdhhc8 Deficiency Disrupts AKT/GSK3b Signaling Cascade
(A) Representative cortical neurons stained for pAKT (S473) (red) and EGFP (green) at DIV3 following ex utero electroporation of shRNA targeting CDC42Palm or
scrambled shRNA.
(B) Quantification of fluorescence intensity reveals that knockdown of CDC42Palm reduces pAKT (S473) intensity at the tip of the axon.
(C) Representative cortical neurons stained for pGSK3b (S9) (red) and EGFP (green) at DIV3 following ex utero electroporation of shRNA targeting CDC42Palm or
scrambled shRNA.
(D) Quantification of fluorescence intensity reveals that knockdown of CDC42Palm reduces pGSK3b (S9) intensity at the tip of the axon.
(E) Representative images of DIV3 cortical neurons immunostained with pAKT(S473) (red) and neuronal marker Tuj1(green) from Zdhhc8-deficient and control
mice.
(F) Quantification of fluorescence intensity reveals that Zdhhc8 deficiency reduces pAKT(S473) intensity at the tip of axon.
(G) Representative images of DIV3 cortical neurons immunostained with pGSK3b(S9) (red) and neuronal marker Tuj1(green) from Zdhhc8-deficient and control
mice.
(H) Quantification of axon tip fluorescence intensity reveals that Zdhhc8 deficiency reduces pGSK3b(S9) intensity at the tip of axon.
Data are shown as means ± SEM. *p < 0.05; **p < 0.001; ***p < 0.0001; Student’s t test.
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Figure 8. SB216763 Treatment Restores Axon Branch Numbers
(A and B) Western blot analysis of lysates of prefrontal cortex from Zdhhc8-deficient mice at 8 weeks demonstrating reduced levels of pAKT(S473) and
pGSK3b(S9).
(C and D) Western blot analysis of lysates of prefrontal cortex from Df16(A)+/ mice at 8 weeks demonstrating reduced levels of pAKT(S473) and pGSK3b(S9).
(E) Representative images of ipsilateral axon branching of EGFP-labeled neurons from coronal sections of SB216763-treated brain at P7.5. Representative
images are a composite of more than one image acquired from one brain section under identical scanning parameters. Image merging planes are indicated by
white dots at the side of each panel.
(F) Traces of axon branches in the ipsilateral cortical layers 2–4 of coronal sections from P7.5 brains in utero electroporated with EGFP at E15.5 and treated with
DMSO or SB216763 from P2 to P7.
(G) Quantification of axon morphology reveals that SB216763 treatment restored axon branch numbers in the ipsilateral cortical layers 2–4. Scale bar, 20 mm.
(H) Representative images of contralateral axon branching of EGFP-labeled neurons from coronal sections of SB216763-treated brain at P7.5.
(I) Traces of axon branches in the contralateral cortical layers 2–4 of coronal sections from P7.5 brains in utero electroporated with EGFP at E15.5 and treatedwith
DMSO or SB216763 from P2 to P7.
(J) Quantification of axon morphology reveals that SB216763 treatment restored axon branch numbers in the contralateral cortical layers 1–4. Scale bar, 20 mm.
Data are shown as means ± SEM. *p < 0.05; **p < 0.001; ***p < 0.0001; Student’s t test.19% and 29% in the Zdhhc8+/ (six mice, n = 18, p < 0.005) and
Zdhhc8/ (six mice, n = 18, p < 0.001) as compared with WT lit-
termates (six mice, n = 18), respectively (Figures 8A and 8B).
Importantly, Df(16)A+/ mice, with only one intact copy of
Zdhhc8, show a significant reduction in the levels of pAkt
(25%; 12 mice, n = 24, p < 0.05) and pGsk3b (19%; 12 mice,
n = 24, p < 0.05), as compared with WT littermates (12 mice,
n = 24) (Figures 8C and 8D).
If alterations of PI3K/Akt/Gsk3b signaling emerge during
brain development, we might be able to reverse deficits in
axonal branching by decreasing Gsk3b activity in developing
Zdhhc8/ mice. To this end, following electroporation with
EGFP plasmids at E15.5, pups were treated with DMSO or
SB216763 (2 mg/kg i.p.), a Gsk3b inhibitor, every day from P2
to P7. Compared to DMSO-treated Zdhhc8/ mice (n = 15,
four brains), Zdhhc8/ mice treated with SB216763 (n = 15,
four brains), showed a 50% increase in the number of axon692 Neuron 86, 680–695, May 6, 2015 ª2015 Elsevier Inc.branches in the ipsilateral layers 2/4 (Figures 8E–8G) reaching
the number of axon branches in WT mice treated with DMSO
(n = 15, four brains). Moreover, we observed that contralateral
primary axonal branches were increased by 72% in Zdhhc8/
mice treated with SB216763 (n = 16, four brains), compared to
Zdhhc8/ mice treated with DMSO (n = 12, four brains), and
restored to the level observed in WT mice treated with DMSO
(n = 12, four brains) (Figures 8H–8J). These findings establish a
causal relationship between altered AKT/GSK3b signaling and
Zdhhc8-dependent axonal branching in vivo.
DISCUSSION
The emerging picture from psychiatric genetics is one of sub-
stantial mutational heterogeneity. Modeling in animals a few
selected mutations with robust and specific disease associa-
tions makes possible gaining insights into fundamental
biological mechanisms that underlie disease pathogenesis and
pathophysiology. In that context, our study provides a series of
insights into the mechanisms governing axonal growth and their
relation to the psychiatric and cognitive phenotypes associated
with a well-established CNV predisposing to schizophrenia.
Using a multipronged approach, we show that impaired palmi-
toylation affects axonal growth both in vitro and in vivo and pro-
vide evidence that altered palmitoylation of key axonal proteins
emerging as a result of the 22q11.2 deletion results in deficits
in axonal arborization and connectivity that affect the formation
and function of neural circuits.
Our analysis focuses on ZDHHC8 palmitoyltransferase, en-
coded by a gene located at the human 22q11.2 deletion locus.
Our findings strongly suggests that Zdhhc8 deficiency accounts
for many of the deficits in axonal morphology and synaptic con-
tacts emerging as a result of a hemizygous deletion of themouse
syntenic 22q11.2 locus and reinforce the notion that reduction in
the dosage of ZDHHC8 is crucial for establishing altered levels of
short- and long-range connectivity in neurons carrying a deletion
of the orthologous 22q11.2 locus.
Identification of bone fide substrates of ZDHHC8, which
included a preponderance of proteins involved in axonal growth,
facilitated elucidation of the mechanistic basis of the observed
effects. Although it is very likely that the observed axonal pheno-
types are caused by combined underpalmitoylation of more than
one of the substrates, we identified a palmitoylated form of
Cdc42 (cell division cycle 42), a RhoGTPase previously shown
to modulate neuronal polarity and elongation as a key molecular
mediator of the effect of altered palmitoylation on axonal growth.
Moreover, our genetic and pharmacological rescue analysis
provided evidence that the effect of ZDHHC8 on axon growth
is mediated in part via Cdc42-dependent modulation of Akt/
Gsk3b signaling in the tip of the axon.
Although many psychiatric disorders, such as schizophrenia,
emerge during adolescence and early adulthood, behavioral ab-
normalities including cognitive impairments are often apparent in
a portion of patients before diagnostic criteria are met (Brewer
et al., 2006). Moreover, genes and cellular pathways implicated
in disease risk play important roles both in the developing and
the mature brain. Both the temporal expression and spatial
expression of ZDHHC8 appear to coincide with peak periods
of cortical synaptogenesis, where the enzyme may be critical
during late embryogenesis and early postnatal life in establishing
formation of short- and long-range connection of neurons that
have migrated into their final destinations. In that respect,
restoring axonal branching during early postnatal development
(by treating mutant pups from P2 to P7 with SB216763) strongly
suggests that early intervention that restores the function of
this disease pathway may have beneficial effects. However,
ZDHHC8 continues to be expressed at high levels in the cortex
through adulthood, and it remains possible that in addition to
its role in the initial formation of cortical circuits, ZDHHC8 func-
tion may continue to play an important role in the adult brain in
regulating synaptic plasticity of these circuits.
Our results inform both the neural and genetic mechanisms of
the disease. First, in schizophrenia and various developmental
and psychiatric disorders, dysconnectivity between and within
brain regions is thought to underlie emergence and severity ofsymptoms across many psychological domains and brain sys-
tems (cognitive, affective, social, motor, and perceptual). The
exact mechanisms behind the spatiotemporal pattern of dys-
connectivity are unknown and likely involve changes in local
neural dynamics as well as alterations in anatomical scaffolding
(e.g., axonal targeting and synaptogenesis in many brain areas)
(Arguello and Gogos, 2012). Our findings advance our under-
standing of how mutations predisposing to psychiatric and
cognitive phenotypes impact circuits and offer one molecular
and cellular basis for the structural dysconnectivity in psychiat-
ric and neurodevelopmental disorders implicating the Zdhhc8
gene and neuronal protein palmitoylation in this process. In
that respect, our observation that Zdhhc8 deficiency can lead
to a specific disruption of vHPC synchrony with the mPFC
and impair WM performance was particularly instructive in
highlighting the necessity of intact terminal arborization of
vHPC projections to mPFC in normal spatial WM. Although
appropriately designed rescue studies are needed to establish
an unequivocal link between Zdhhc8 and hippocampal-cortical
synchrony, our findings suggest an important role for palmitoy-
lation in shaping efficient long-range connectivity between brain
structures.
Second, an emerging view of schizophrenia is that rare alleles
contribute significantly to a large proportion of overall genetic
risk, whereas secondary modifiers (other rare or common alleles)
that regulate the function of key cellular signaling pathways
determine the trajectory and severity of the clinical manifesta-
tions resulting from a primary disease-causing mutation. In that
context, it is worth noting that an increasingly strong link be-
tween a dysregulation of Akt and Cdc42 signaling and schizo-
phrenia is emerging in humans and an association between
schizophrenia and common Akt1 and Cdc42 genetic variants
has been reported in several patient cohorts (Arguello and Go-
gos, 2008; Gilks et al., 2012; Ide and Lewis, 2010).
It is also important to consider the implications of our findings
for the 22q11.2 locus-associated risk. Existing structural and
functional neuroimaging work in 22q11.2 deletion carriers have
detected structural abnormalities in white-matter volumetric
andDTI measures as well as altered resting-state functional con-
nectivity (Jalbrzikowski et al., 2014; Baker et al., 2011; Ottet
et al., 2013; Schreiner et al., 2014). Together these studies found
an overall global loss of connectivity as well as deficits in long-
range connectivity in children with 22q11.2 deletions. Our find-
ings of microscopic structural alterations in axonal branching in
conjunction with current and previous finding of altered synaptic
transmission and plasticity in cortical synapses of Df(16)A+/
mice (Fe´nelon et al., 2011, 2013) offer a plausible neural sub-
strate that may underlie the mesoscopic scale neuroimaging
findings. In addition, accumulating data link neuroimaging mea-
sures with the psychosis phenotype in 22q11.2 deletion carriers,
providing support for the notion that structural and functional
dysconnectivity is particularly relevant to the psychosis pheno-
type in 22q11DS (Kates et al., 2015; Perlstein et al., 2014; Jalbr-
zikowski et al., 2014; Ottet et al., 2013). In that respect, our data
suggest that the altered axonal connectivity that emerges as a
result of deficits in neuronal palmitoylation contribute to the psy-
chiatric deficits associated with the 22q11 deletion. Our findings
should be interpreted in the context of decreases in the dosageNeuron 86, 680–695, May 6, 2015 ª2015 Elsevier Inc. 693
of neighboring genes that would have a cumulative effect on the
properties of neural networks, but themolecular substrates iden-
tified heremay inform new treatments of the 22q11.2-associated
psychiatric symptoms.
Overall, our results demonstrate how bona fide mutations
interact with disease-associated signaling pathways that can
mediate (and therefore also modify) the effects of a primary mu-
tation on a cellular substrate (axonal connectivity). Translating
interaction among primary mutations and signaling pathways
at the levels of circuits and neural systems represents a decisive
step toward valuable mechanistic insights into the pattern and
severity of cognitive and psychiatric symptoms and thus can
provide a key to understanding genetic and neural mechanisms
underlying disease risk.
EXPERIMENTAL PROCEDURES
Zdhhc8 and Df(16)A+/– Transgenic Mice
Zdhhc8 knockout mice were generated and genotyped as previously
described (Mukai et al., 2004). The Df(16)A+/ mice were generated and gen-
otyped as previously described (Stark et al., 2008). The expected reduction or
elimination of Zdhhc8 transcript levels in the brain was confirmed by quantita-
tive real-time PCR (Mukai et al., 2008). All animal procedures were conducted
according to protocols approved by the Institutional Animal Care and Use
Committee established by Columbia University under federal and state
regulations.
Electroporatlon In Utero
Pregnant mothers with E14.5–16.5 embryos were anaesthetized, and a 1 inch
incision was made and one uterine horn removed. A total of 0.1–0.5 ml DNA
(1–2 mg/ml) was injected into one ventricle. Four to five 40–48 V pulses were
applied, each pulse lasting 50 ms, with a 1 s pause between each pulse using
an ECM-830 square wave electroporatoror (BTX) as previously described
(Saito, 2002).
Drug Injection
SB216763 was dissolved in DMSO (20 mg/ml) as the stock solution. Before
each injection, the stock solution was freshly diluted to 2 mg/ml with
PEG400. Final concentration for each pup is 2 mg/kg. Mice were treated
with either control DMSO or SB216763 (2 mg/kg i.p.) every day from P2 to
P7 at 9 a.m. Mice were perfused with PBS and 4% paraformaldehyde at
5 p.m. in P7.
ABE assay, expression constructs, immunocytochemistry, immunohisto-
chemistry, image acquisition and quantification, cell culture, transfection,
westernblot, behavior analysis, electrophysiology, and frontal cortex sliceprep-
aration are described in detail in the Supplemental Experimental Procedures.
SUPPLEMENTAL INFORMATION
Supplemental Information includes six figures and Supplemental Experimental
Procedures and can be found with this article at http://dx.doi.org/10.1016/j.
neuron.2015.04.003.
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